Possible peroxidase active site environment in amyloidogenic proteins: Native monomer or misfolded-oligomer; which one is susceptible to the enzymatic activity, with contribution of heme?

Design and application of histidine-functionalized ZnCr-LDH nanozyme for promoting bacteria-infected wound healing

Excessive use of antibiotics can lead to an increase in antibiotic-resistant bacteria, which makes it a serious health threat. Therefore, developing new materials with antibacterial activity, such as nanozymes, has gained considerable attention. Reactive oxygen species (ROS) produced by nanozymes have rapid and effective antibacterial efficacy. Here, histidine (His) modified ZnCr layered double hydroxide (LDH) was synthesized inspired by the natural enzyme, and the enzyme-like activity of His/ZnCr-LDH was tested using a colorimetric method. Then, we developed an acid-enhanced antibacterial method based on the high peroxidase-like activity of His/ZnCr-LDH, and its ROS-generating capability in the presence of glucose oxidase (GOx) and glucose (Glu) as a source of hydrogen peroxide (H2O2). Gluconic acid (GA), the main product of the GOx reaction, provides an acidic environment and promotes ROS generation. The mentioned strategy shows high antibacterial activity at a low minimum inhibitory concentration (MIC) which represents the potential of His/ZnCr-LDH for effective bacterial elimination (3.5 μg mL-1 for S. aureus and 6 μg mL-1 for E. coli). In addition, animal experiments illustrated that the His/ZnCr-LDH can successfully boost the curing of infected wounds. The outcomes indicate that amino acid modified LDHs offer a new strategy for effective bacterial removal in different medical applications.

Pyridine-2,3-dicarboxylate, quinolinic acid, induces 1N4R Tau amyloid aggregation in vitro: Another evidence for the detrimental effect of the inescapable endogenous neurotoxin

Quinolinic acid (QA) known as a neuro-active metabolite associated with the kynurenine pathway. At high concentrations, QA is often involved in the initiation and development of several human neurologic diseases, like Alzheimer's disease. Because of the QA action as the NMDA receptor, it is considered as a potent excitotoxin in vivo. Since it is probable that different mechanisms are employed by QA, activation of NMDA receptors cannot fully explain the revealed toxicity and it is even believed that there are multiple unknown mechanisms/targets leading to QA cytotoxicity. Herein we report accelerated amyloid oligomerization of 1N4R Tau under the effect of QA, in vitro, then the molecular structure, morphology and toxicity of the protein aggregate were documented by using various theoretical/experimental approaches. The possible mechanism of action of QA-induced Tau oligomerization has also been explored.

Is there correlation between Aβ-heme peroxidase activity and the peptide aggregation state? A literature review combined with hypothesis

Alzheimer's disease (AD) is an age-related neurodegenerative disorder characterized by aggregation of amyloid-β (Aβ) peptide, formation of neurofibrillary tangles, synaptic loss and neuronal cell death, and is manifested clinically by progressive cognitive dysfunction and memory loss. Disease pathogenesis is mainly linked to the formation of Aβ insoluble or soluble oligomeric assemblies. Binding of heme to Aβ has been suggested as the origin of the heme deficiency, peroxidase activity, as well as some oxidative stress-mediated AD pathologies, and then differential affinity of heme for human and rodent Aβ peptide has been proposed to account for the susceptibility of humans to AD. This review highlights whether there is any dependency of peroxidase activity of heme-bound Aβ on the Aβ aggregation state or not, with focusing on emerging role of heme in neurodegeneration. Here, several lines of evidence supporting existing contradictory conjectures are discussed.